# Guangxi Yulin Pharmaceutical Group Co. Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/guangxi-yulin-pharmaceutical-group-co-ltd/3815cb2a-39f8-4338-9e21-e6dcd7f7a015

> Inspection records and compliance data for Guangxi Yulin Pharmaceutical Group Co. Ltd. in Yulin, None. Access full analysis and detailed observations.

---

## Details

- Name: Guangxi Yulin Pharmaceutical Group Co. Ltd.
- FEI Number: 1000589993
- City: Yulin
- State: None
- Country Name: China
- Address Line 1: 1 Chengzhan Road
- Zip Code: None

## Related Documents

- [483 - Guangxi Yulin Pharmaceutical Group Co. Ltd. - 2025-03-21](https://www.keypedia.com/records/483/guangxi-yulin-pharmaceutical-group-co-ltd/5c329ca0-cc1d-4df7-b776-7e4693ad5b7f) — source: FDA, date: March 21, 2025
- [WARNING_LETTER - Guangxi Yulin Pharmaceutical Group Co. Ltd. - 2025-03-21](https://www.keypedia.com/records/warning_letter/guangxi-yulin-pharmaceutical-group-co-ltd/87d84374-5040-4430-a8c7-a435768ffa74) — source: FDA, date: March 21, 2025
- [FDA Inspection 1268116 - Guangxi Yulin Pharmaceutical Group Co. Ltd. - 2025-03-21](https://www.keypedia.com/records/fda_inspections/guangxi-yulin-pharmaceutical-group-co-ltd/82a89afe-506e-4e84-9dd2-02a225853a04) — source: FDA, date: March 21, 2025
- [FDA Inspection 992915 - Guangxi Yulin Pharmaceutical Group Co. Ltd. - 2016-09-29](https://www.keypedia.com/records/fda_inspections/guangxi-yulin-pharmaceutical-group-co-ltd/53547aca-4a56-4e32-a161-c8403b574891) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2016
- [FDA Inspection 992915 - Guangxi Yulin Pharmaceutical Group Co. Ltd. - 2016-09-29](https://www.keypedia.com/records/fda_inspections/guangxi-yulin-pharmaceutical-group-co-ltd/3234756c-c4c4-4f85-9e17-82bfde214835) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2016
- [FDA Inspection 748465 - Guangxi Yulin Pharmaceutical Group Co. Ltd. - 2011-09-22](https://www.keypedia.com/records/fda_inspections/guangxi-yulin-pharmaceutical-group-co-ltd/3b262c58-6d65-429e-affe-36929fbbb2e4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 22, 2011

## Related Companies

- [Episciences Inc](https://www.keypedia.com/companies/episciences-inc/db9de422-87ad-44ad-bf37-a1cd35fdb978)
- [Strukmyer LLC](https://www.keypedia.com/companies/strukmyer-llc/e88a21a5-5cb3-44cb-be17-5ae442aee17e)
- [Milbar Laboratories, Inc.](https://www.keypedia.com/companies/milbar-laboratories-inc/f2d60bc9-405c-493a-a422-7a93d38d883b)
- [Gadal Laboratories Inc.](https://www.keypedia.com/companies/gadal-laboratories-inc/ab020b2d-bc0c-4731-bc27-f75fc34163d4)
- [Delcath Systems Inc.](https://www.keypedia.com/companies/delcath-systems-inc/ce3ea8cb-f842-43a9-9eb4-91e58e74932b)
- [Allay Pharmaceuticals, LLC](https://www.keypedia.com/companies/allay-pharmaceuticals-llc/20d57aab-16cc-49b7-aa6a-1e9942240fa8)
- [InvaDerm, Inc.](https://www.keypedia.com/companies/invaderm-inc/33416b4a-1d16-4adf-987e-d5970ac5f9a2)
- [Fuller Industries, Inc](https://www.keypedia.com/companies/fuller-industries-inc/c156f0dc-cacf-47b2-9cc5-007269d292ff)
- [Alcami Carolinas Corporation](https://www.keypedia.com/companies/alcami-carolinas-corporation/b3301d1d-4fec-4888-82e6-d950811aab7c)
- [Amol Pharmaceuticals Private Ltd.](https://www.keypedia.com/companies/amol-pharmaceuticals-private-ltd/25109535-73e8-434b-98f1-01695cc33434)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/gavin-t-cua/6f498dd6-2c4b-42e9-8ddc-3c2a7c97afef)
- [Crystal Monroy](https://www.keypedia.com/people/crystal-monroy/b0414886-fb71-4f35-a453-0ad2baf13bfc)
- [Director](https://www.keypedia.com/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)